Burning Rock Biotech Limited
BNR
$5.76
$0.264.73%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.97M | 17.50M | 16.77M | 16.77M | 17.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.97M | 17.50M | 16.77M | 16.77M | 17.61M |
| Cost of Revenue | 5.14M | 5.56M | 5.95M | 5.95M | 5.75M |
| Gross Profit | 12.83M | 11.94M | 10.82M | 10.82M | 11.86M |
| SG&A Expenses | 11.35M | 20.27M | 23.73M | 23.73M | 24.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.36M | 35.02M | 39.81M | 39.81M | 42.30M |
| Operating Income | -5.39M | -17.53M | -23.04M | -23.04M | -24.69M |
| Income Before Tax | -4.97M | -16.91M | -22.32M | -22.32M | -24.10M |
| Income Tax Expenses | 28.10K | 25.10K | 148.30K | 148.30K | 62.10K |
| Earnings from Continuing Operations | -4.99M | -16.93M | -22.47M | -22.47M | -24.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.99M | -16.93M | -22.47M | -22.47M | -24.16M |
| EBIT | -5.39M | -17.53M | -23.04M | -23.04M | -24.69M |
| EBITDA | -799.90K | -12.95M | -18.48M | -18.48M | -20.52M |
| EPS Basic | -4.84 | -16.51 | -21.94 | -21.94 | -23.61 |
| Normalized Basic EPS | -0.30 | -1.03 | -1.36 | -1.36 | -1.47 |
| EPS Diluted | -4.84 | -16.51 | -21.94 | -21.94 | -23.61 |
| Normalized Diluted EPS | -0.30 | -1.03 | -1.36 | -1.36 | -1.47 |
| Average Basic Shares Outstanding | 10.32M | 10.25M | 10.24M | 10.24M | 10.23M |
| Average Diluted Shares Outstanding | 1.03M | 1.03M | 1.02M | 1.02M | 1.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
